HB470 Summary

• Prohibits occupational licensing boards from revoking, suspending, or taking adverse action against a physician's license based solely on the physician's recommendation of non-FDA-approved COVID-19 treatments, provided the physician exercised independent medical judgment and obtained written informed consent from the patient.

• Requires patients to provide written, informed consent before receiving non-FDA-approved COVID-19 treatments, which must include explanation of FDA-approved treatments, identification of the proposed treatment, description of potential outcomes including death, and release of liability for treating physicians, health care providers, and manufacturers.

• Prohibits pharmacies from blocking or attempting to block a patient's access to non-FDA-approved drugs, biological products, or devices prescribed by a physician to treat COVID-19.

• Requires health care facilities to provide patients with requested off-label use of FDA-approved drugs, biological products, or devices for COVID-19 treatment.

• Provides patients and physicians with causes of action in circuit court against violating entities, with available remedies including injunctive relief, reinstatement of licenses, and reasonable attorney fees and court costs.